Back to news
Laura Soucek (ICREA @ VHIO) and Marie-Eve Beaulieu are the Peptomyc entrepreneurs that last year started the company and raised 1M to reach proof of concept stage. After sucessfully completing the first milestones, they have now secured asecond round.The investment was led by Barcelona based investors Alta Life Sciences and raised more than 4 million euros to develop their promising oncology treatment. In a nutshell, their technology is based on blocking the gene Myc, which is essential for the survival of cancer cells (and only those!) We wish them all the best and hope that this can become a treatment in the future.
See attached the press release, and click here to go to VHIO‘s website and find out more about the science behind this breakthrough.
OTHER NEWS
ICREA Research Professor Thomas Sturm (UAB) will participate in the ecas-Europe 2026 State of the Union Citizens’ Rights Conference, talking about the “Fifth Freedom”, the freedom of knowledge
Prof. Thomas Sturm will be contributing to the second panel on the Fifth Freedom within the European Union. The conference…
Catalan National Research Awards 2025
ICREA researchers Luis Serrano and Katherine Villa have been awarded at the 36th edition of the 'Premis Nacionals de Recerca'…
